1Stampfer MJ, Willett WC, Cloditz GA, et al, A prospective study of postmenopausal estrogen therapy and coronary heart disease[J]. N Engl J Med, 1985,313:1044- 1049.
2Hlley S, Grady D, Bush T, et al. For the Heart and Estrogen/ progestin Replacement Study (HERS) Rresearch Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [ J ] . JAMA, 1998,280:605 - 613.
3Crodstein F, Manson JE, Coldizt CA, Willett WC, et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cadiovaseular disease [ J ]. Ann Intern Med, 2000,1333:933- 941.
4Grady D, Herrington D, Bittner V, et al, for the HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow - up( HESRS II) [ J ]. JAMA, 2002, 288( 1 ) :49 -57.
5Writing group for the women's health Initiative investigators. Risks and benefits ot zetrogen plus progestin in healthy postmenopausal Women. Principal results from the women's health initiative randomized controlled trial [J]. JAMA, 2002, 288(3):321 - 333.
6Hlley S, Grady D, Bush T, et al. For the Heart and Estrogen/progestin Replacement Study (HERS) Rresearch Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women[J]. JAMA, 1998,280:605-6
7Grady D, Herrington D, Bittner V, et al, for the HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up(HESRS II)[J]. JAMA, 2002, 288(1):49-57.
8Writing group for the women's health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal Women. Principal results from the women's health initiative randomized controlled trial[J]. JAMA, 2002, 288(3):321-333.
9Stampfer MJ, Willett WC, Cloditz GA, et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease[J]. N Engl J Med, 1985,313:1044-1049.
10Grodstein F, Manson JE, Coldizt GA, Willett WC, et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cadiovascular disease[J]. Ann Intern Med, 2000,1333:933-941.
